This article provides an overview of a systematic review and network meta-analysis that compares the effectiveness and safety of different tobacco cessation pharmacotherapies and electronic cigarettes.
It highlights that most treatments are more effective than placebo, with varenicline showing the highest effectiveness, and notes limited evidence of adverse effects, emphasizing the need for better safety data reporting.